Physician

Nicholas Joseph Golda, M.D.

According to 2025 Medicare claims, Nicholas Golda, M.D. (NPI: 1053421081) practices dermatology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Jackson, MO. This provider's primary affiliated billing organization is DERMATOLOGY AND SKIN CANCER SPECIALISTS, LLC. (NPI: 1366632697; TIN: 861072868) and primary practice location at 64064-2301.

Golda's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,158 traditional Medicare patients, billed 6,324 HCPCS/CPT codes, and received $548,932 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 1,260 prescription claims across 884 beneficiaries totaling $15,990 in drug costs, led by Doxycycline Hyclate (Doxycycline Hyclate). Open Payments data shows 44 records totaling $1,683. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $311,103 to $548,932. Similarly, Part D prescription costs have risen steadily, from $1,946 to $15,990. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	503	2,148	$311,103
2016	490	2,161	$333,263
2017	464	2,203	$361,425
2018	487	1,931	$340,603
2019	502	1,890	$349,530
2020	449	1,778	$320,191
2021	435	1,669	$290,114
2022	678	2,705	$359,927
2023	960	5,382	$512,501
2024	1,158	6,324	$548,932

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	121	153	$1,946
2016	93	104	$1,960
2017	155	191	$2,783
2018	169	243	$5,197
2019	187	232	$3,487
2020	189	236	$4,630
2021	179	220	$3,194
2022	402	480	$6,827
2023	743	1,075	$16,212
2024	884	1,260	$15,990

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	392	565	$250
11102	Biopsy of related skin growth, first growth	329	395	$62
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	735	903	$59
17000	Destruction of precancer skin growth, 1 growth	473	653	$37
17003	Destruction of precancer skin growth, 2-14 growths	317	1,534	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Doxycycline Hyclate	Doxycycline Hyclate	894	7,853	$7,088
Clobetasol Propionate	Clobetasol Propionate	33	992	$1,988
Ketoconazole	Ketoconazole	56	1,795	$1,167
Metronidazole	Metronidazole	29	901	$1,030
Triamcinolone Acetonide	Triamcinolone Acetonide	62	2,007	$808

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	43	$1,057	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$626	Regeneron Pharmaceuticals, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nicholas Joseph Golda, M.D.?

Tedicare shows public-source Medicare data for Nicholas Joseph Golda, M.D. (NPI 1053421081), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nicholas Joseph Golda, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nicholas Joseph Golda, M.D.?

Nicholas Joseph Golda, M.D. is linked to DERMATOLOGY AND SKIN CANCER SPECIALISTS, LLC. (billing NPI 1366632697) in the available physician profile data.

Does Nicholas Joseph Golda, M.D. have Open Payments data?

Nicholas Joseph Golda, M.D. has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.